Panbela Therapeutics Inc (PBLA)
0.41
-0.02
(-4.65%)
USD |
OTCM |
May 01, 15:58
Panbela Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
September 29, 2023 | 0.807 |
September 28, 2023 | 0.7885 |
September 27, 2023 | 0.8008 |
September 26, 2023 | 0.7885 |
September 25, 2023 | 0.77 |
September 22, 2023 | 0.7638 |
September 21, 2023 | 0.807 |
September 20, 2023 | 0.8131 |
September 19, 2023 | 0.8254 |
September 18, 2023 | 0.807 |
September 15, 2023 | 0.8131 |
September 14, 2023 | 0.8193 |
September 13, 2023 | 0.8501 |
September 12, 2023 | 0.8624 |
September 11, 2023 | 0.8316 |
September 08, 2023 | 0.8501 |
September 07, 2023 | 0.8747 |
September 06, 2023 | 0.9055 |
September 05, 2023 | 0.8994 |
September 01, 2023 | 0.8932 |
August 31, 2023 | 0.8562 |
August 30, 2023 | 0.8501 |
August 29, 2023 | 0.8316 |
August 28, 2023 | 0.8193 |
August 25, 2023 | 0.8131 |
Date | Value |
---|---|
August 24, 2023 | 0.807 |
August 23, 2023 | 0.8747 |
August 22, 2023 | 0.8747 |
August 21, 2023 | 0.9363 |
August 18, 2023 | 0.9425 |
August 17, 2023 | 0.9425 |
August 16, 2023 | 0.9671 |
August 15, 2023 | 0.924 |
August 14, 2023 | 1.010 |
August 11, 2023 | 0.9979 |
August 10, 2023 | 1.041 |
August 09, 2023 | 1.066 |
August 08, 2023 | 1.133 |
August 07, 2023 | 1.047 |
August 04, 2023 | 0.9362 |
August 03, 2023 | 1.017 |
August 02, 2023 | 1.028 |
August 01, 2023 | 1.055 |
July 31, 2023 | 1.093 |
July 28, 2023 | 1.082 |
July 27, 2023 | 1.034 |
July 26, 2023 | 1.088 |
July 25, 2023 | 1.115 |
July 24, 2023 | 1.120 |
July 21, 2023 | 1.180 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4997
Minimum
Jun 20 2023
53.25
Maximum
May 13 2020
11.85
Average
4.739
Median
Jan 20 2021
Price to Book Value Benchmarks
Processa Pharmaceuticals Inc | 1.294 |
Fate Therapeutics Inc | 1.099 |
Ardelyx Inc | 9.206 |
Checkpoint Therapeutics Inc | -- |
Palisade Bio Inc | 0.5292 |
Price to Book Value Related Metrics
PS Ratio | 0.0627 |
Price | 0.41 |
Earnings Yield | -150.3K% |
Market Cap | 1.991M |